Agenda – IMI2-Call 20 Webinar - Thursday, 12 December 2019, 10:00 - 11:45 a.m.

10:00

Welcome
Sebastian Hiessl (VBU)
Siegfried Throm (vfa und vfa bio)
Caroline Töx (National Contact Point Health, NKS-G)

   
10:10

IMI2 Call process & future topics in IMI2
Matthias Gottwald, Bayer AG

   
10:20

IMI2 Application and support by BMBF/National Contact Point Health 
Caroline Töx, NKS-G
 

IMI2 Call 20 - Topics (incl. Q&A after each topic)
 

10:30

Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in Psoriatic Arthritis

Bruno Boutouyrie-Dumont, Novartis

   
10:40 Topic 2: Innovations to accelerate vaccine development and manufacture
Landry Cochard, GSK 
   
10:50 Topic 3: Tumour plasticity
Holger Hess-Stumpp, Bayer AG
   
11:00 Topic 4: Proton versus photon therapy for oesophageal cancer – a trimodality strategy
Michael Schillo, Varian 
   
11:10

Topic 5: Handling of protein drug products and stability concerns
Marc Dietrich Voss, Sanofi

   
11:20 Topic 6: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
David Barros-Aguirre, GSK
   
11:30 End of webinar
   

The registration is closed from now on

  

 

Zur Datenschutzerklärung der DECHEMA: http://dechema.de/datenschutz.html

Wiederspruchsrecht: http://dechema.de/datenschutz.html#Widerspruchsrecht

Kontakt:

Frau Dr. Sydow

vfa bio 030/20604-310

s.sydow(at)vfa.de    

Herr Dr. Hiessl

VBU 069/7564-301

sebastian.hiessl(at)dechema.de    

Frau Töx

NKS-G 0228/3821-2043

Caroline.Toex(at)dlr.de

VBU Info

Veranstalter

Technischer Support

cme24 Ltd.
Zeppelinstr. 2
76185 Karlsruhe
Tel: +49 (0)721 9595 611
E-Mail: support@cme24.de

© 2007-2020 cme24 ltd.